Status
Conditions
Study type
Funder types
Identifiers
About
The main objective of the pilot phase of PGLEXPO will be to assess the faisability and to precise methodology of a case-control study designed for testing the impact of environmental and professional exposures on the tumoral risk in SDHx-mutation carriers
Full description
The main objective of the pilot phase of PGLEXPO will be to assess the faisability and to precise methodology of a case-control study designed for testing the impact of environmental and professional exposures on the tumoral risk in SDHx-mutation carriers.
Patients will be selected from subjects with a mutation in one of the SDHx genes. The cases will have developed a tumor, while the controls will be tumor-free. Controls will be matched to the cases according to sex, age and type of gene affected. Past exposures will be sought through a telephone questionnaire.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Incapacity to exercise free and informed consent for the study
Loading...
Central trial contact
Alexandre BUFFET, MD, PhD; Anne-Paule GIMENEZ-ROQUEPLO, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal